| Metal–phenolic network-based nanocomplexes that evoke ferroptosis by apoptosis: promoted nuclear drug influx and reversed drug resistance of cancer Y Guo, X Zhang, W Sun, HR Jia, YX Zhu, X Zhang, N Zhou, FG Wu Chemistry of Materials 31 (24), 10071-10084, 2019 | 105 | 2019 |
| Mitochondria-acting nanomicelles for destruction of cancer cells via excessive mitophagy/autophagy-driven lethal energy depletion and phototherapy YX Zhu, HR Jia, G Gao, GY Pan, YW Jiang, P Li, N Zhou, C Li, C She, ... Biomaterials 232, 119668, 2020 | 80 | 2020 |
| JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States LE Stevens, G Peluffo, X Qiu, D Temko, A Fassl, Z Li, A Trinh, ... Cancer research 83 (2), 264-284, 2023 | 27 | 2023 |
| CoBRA: containerized bioinformatics workflow for reproducible ChIP/ATAC-seq analysis X Qiu, AS Feit, A Feiglin, Y Xie, N Kesten, L Taing, J Perkins, S Gu, Y Li, ... Genomics, Proteomics and Bioinformatics 19 (4), 652-661, 2021 | 25* | 2021 |
| Repurposing Erythrocytes as a “Photoactivatable Bomb”: A General Strategy for Site‐Specific Drug Release in Blood Vessels YX Zhu, HR Jia, Y Guo, X Liu, N Zhou, P Liu, FG Wu Small 17 (34), 2100753, 2021 | 18 | 2021 |
| FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer research 82 (17), 2980-3001, 2022 | 7 | 2022 |
| scATAnno: Automated Cell Type Annotation for single-cell ATAC-seq Data Y Jiang, Z Hu, J Jiang, A Zhu, Y Zhang, AW Lynch, Y Xie, R Li, N Zhou, ... bioRxiv, 2023.06. 01.543296, 2023 | 1 | 2023 |
| Combination therapies to improve the efficacy of immunotherapy in triple-negative breast cancer M Alečković, Z Li, N Zhou, X Qiu, B Lulseged, P Foidart, XY Huang, ... Molecular Cancer Therapeutics 22 (11), 1304-1318, 2023 | | 2023 |
| DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS J Tsai, P Cejas, M Coppola, D Wang, S Patel, D Wu, P Arounleut, X Wei, ... Neuro-Oncology 25 (Supplement_1), i17-i17, 2023 | | 2023 |
| Dissecting mechanisms underlying FOXR2-mediated gliomagenesis in diffuse midline gliomas JW Tsai, P Cejas, M Coppola, DK Wang, S Patel, DW Wu, P Arounleut, ... Cancer Research 83 (7_Supplement), 3562-3562, 2023 | | 2023 |
| FOXR2 is an oncogenic driver across adult and pediatric cancers JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Cancer Research 82 (12_Supplement), 5730-5730, 2022 | | 2022 |
| DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers JW Tsai, P Cejas, DK Wang, S Patel, DW Wu, P Arounleut, X Wei, N Zhou, ... Neuro-Oncology 24 (Supplement_1), i21-i22, 2022 | | 2022 |
